The SELECT trial (2023) demonstrated that Wegovy significantly reduces major adverse cardiovascular events (MACE) heart attack, stroke, cardiovascular death in patients with established cardiovascular disease and obesity
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an italian case-control study
Our findings suggest that GLP-1 receptor agonists, in particular, may have a protective effect on brain health. The findings, published in the journal JAMA Neurology, provide some of the best evidence to date that certain weight loss drugs may help to protect against Alzheimers disease
Foresman JB, Fox DJ
The proposed mechanism involves MMP-1, a specific matrix metalloproteinase
[] This cytokine-driven disruption in glucose metabolism may further impact melanocyte health, as T cell-mediated immunity, particularly the presence of CD4+ and CD8+ T cells at the dermal-epidermal junction, contributes to melanocyte destruction